Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that demonstrate the potential of TECVAYLI® ...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced it will present data on potential treatments for pancreatic and gastric/gastroesophageal junction (G/GEJ) ...
Whatever's hitting that pavement, the untreated surfaces, is making things very slippery, and that does include your driveway, your back porch, even your sidewalk, and you'll notice again we have 37 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback